IRTKS与胃癌患者的进展及生存时间相关
研究用免疫组化检测527例人胃癌标本中IRTKS水平,并构建IRTKS缺陷与p53缺陷小鼠观察生存时间、分离小鼠胚胎成纤维细胞评估体内致瘤性。结果示IRTKS在胃癌中显著高表达且与野生型p53表达负相关;野生型p53患者中高IRTKS者生存时间较短,IRTKS经泛素/蛋白酶体途径促进p53降解。
要点
- IRTKS在胃癌中显著高表达,并与野生型p53表达呈负相关。
- 野生型p53胃癌患者中,高IRTKS表达者生存时间较短(p=0.0153)。
- IRTKS过表达经泛素/蛋白酶体途径促进p53泛素化与降解。
核心结论
- IRTKS过表达经泛素/蛋白酶体途径促进p53降解,与野生型p53胃癌患者的进展及总生存时间呈负相关。
研究设计与样本
- 采用免疫组化检测527例人胃癌标本中IRTKS水平。
- 构建IRTKS缺陷与p53缺陷小鼠,观察生存时间并分离小鼠胚胎成纤维细胞评估体内致瘤性。
- 采用免疫共沉淀研究p53、MDM2与IRTKS的相互作用及p53泛素化。
主要发现
- IRTKS在人胃癌中显著高表达,与野生型p53表达呈负相关。
- 野生型p53患者(n=206)中,高IRTKS表达者(n=141)生存时间短于低IRTKS表达者(n=65)(p=0.0153)。
- IRTKS缺陷的杂合p53+/-小鼠肿瘤发生显著延迟、无瘤生存时间延长。
- 无IRTKS的p53+/-小鼠胚胎成纤维细胞体内致瘤性减弱。
- IRTKS缺失上调p53及其靶基因如BAX和p21。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND AND OBJECTIVES: IRTKS functions as a novel regulator of tumour suppressor p53; however, the role of IRTKS in pathogenesis of gastric cancer is unclear. DESIGN: We used immunohistochemistry to detect IRTKS levels in 527 human gastric cancer specimens. We generated both IRTKS-deficient and p53-deficient mice to observe survival time of these mice and to isolate mouse embryonic fibroblasts (MEFs) for evaluating in vivo tumorigenicity. Co-immunoprecipitation was used to study the interaction among p53, MDM2 and IRTKS, as well as the ubiquitination of p53. RESULTS: IRTKS was significantly overexpressed in human gastric cancer, which was conversely associated with wild-type p53 expression. Among patients with wild-type p53 (n=206), those with high IRTKS expression (n=141) had a shorter survival time than those with low IRTKS (n=65) (p=0.0153). Heterozygous p53+/- mice with IRTKS deficiency exhibited significantly delayed tumorigenesis and an extended tumour-free survival time. p53+/- MEFs without IRTKS exhibited attenuated in vivo tumorigenicity. IRTKS depletion upregulated p53 and its target genes, such as BAX and p21. Intriguingly, IRTKS overexpression promoted p53 ubiquitination and degradation in MEFs and gastric cancer cells. Under DNA damage conditions, IRTKS was phosphorylated at Ser331 by the activated Chk2 kinase and then dissociated from p53, along with the p53-specific E3 ubiquitin ligase MDM2, resulting in attenuated p53 ubiquitination and degradation. CONCLUSION: IRTKS overexpression is negatively correlated with progression and overall survival time of patients with gastric cancer with wild-type p53 through promotion of p53 degradation via the ubiquitin/proteasome pathway.
引用
- Huang LY, Wang X, Cui XF, et al. IRTKS is correlated with progression and survival time of patients with gastric cancer. Gut. 2017. PMID: 28647685. doi:10.1136/gutjnl-2016-313478
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。